1.8800
+0.0300
+(1.62%)
At close: March 3 at 12:06:25 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DANSEY ROGER D Director | Conversion of Exercise of derivative security | May 15, 2024 | 6,749 |
| HUMEAU LAURENT M Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 29,559 |
| KIES PETER D Chief Financial Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 28,427 |
| MILLER ANN CALBY M.D. Director | Conversion of Exercise of derivative security | May 15, 2024 | 7,710 |
| SHEA JACQUELINE ELIZABETH Chief Executive Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 46,550 |
| SHEPARD JAY P. Director | Conversion of Exercise of derivative security | May 15, 2024 | 7,042 |
| SUMNER MICHAEL JOHN Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 13,229 |
| WEINER DAVID B Director | Conversion of Exercise of derivative security | Feb 26, 2025 | 84,453 |
| YARNO WENDY L Director | Conversion of Exercise of derivative security | May 15, 2024 | 8,345 |
| ZOTH LOTA S Director | Conversion of Exercise of derivative security | May 15, 2024 | 6,559 |
Related Tickers
6XP.SG Xspray Pharma AB (publ)
2.7700
-0.36%
6XY.F HBM Holdings Limited
0.6450
+4.88%
CRO.BE Open Orphan PLC
0.1990
0.00%
8JD.F Valbiotis SA
1.2760
+1.11%
I5X.F Precigen, Inc.
1.6450
+4.58%
HPHA.F Heidelberg Pharma AG
2.6300
-5.73%
CRO.F hVIVO plc
0.1740
+4.82%
OPORF hVIVO plc
0.2400
-31.43%
8C5.F Coherus BioSciences, Inc.
1.0195
-0.44%
2LB.F Iovance Biotherapeutics, Inc.
3.8710
-2.32%